HIA
VIE

Harbor Investment Advisory’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Harbor Investment Advisory’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7
Closed – – 1283
2020
Q2 		$0 Buy
+7
New +$317 ﹤0.01% 1246

Other funds holding VIE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Harbor Investment Advisory's VIE Position: Q3 2020 in Review

Harbor Investment Advisory sold out of Viela Bio, Inc. Common Stock (VIE) in Q3 2020, closing a stake of 7 shares.

Harbor Investment Advisory first reported a position in VIE in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 60 funds tracked by Wall St. Rank hold VIE as of Q3 2020.

  • Harbor Investment Advisory reported no remaining Viela Bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Harbor Investment Advisory sold 7 Viela Bio, Inc. Common Stock shares in Q3 2020.
  • Harbor Investment Advisory first reported a position in Viela Bio, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Harbor Investment Advisory's Viela Bio, Inc. Common Stock position peaked at $0 in Q2 2020.
  • 60 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q3 2020.

Based on Harbor Investment Advisory's 13F filing for Q3 2020, filed 23 Oct 2020.